These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29217774)

  • 1. Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.
    Schneider E; Staffas A; Röhner L; Malmberg ED; Ashouri A; Krowiorz K; Pochert N; Miller C; Wei SY; Arabanian L; Buske C; Döhner H; Bullinger L; Fogelstrand L; Heuser M; Döhner K; Xiang P; Ruschmann J; Petriv OI; Heravi-Moussavi A; Hansen CL; Hirst M; Humphries RK; Rouhi A; Palmqvist L; Kuchenbauer F
    Haematologica; 2018 Feb; 103(2):246-255. PubMed ID: 29217774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
    Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
    Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.
    Arabanian LS; Johansson P; Staffas A; Nilsson T; Rouhi A; Fogelstrand L; Palmqvist L
    Leuk Res; 2018 Dec; 75():61-68. PubMed ID: 30384975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia.
    Mohr S; Doebele C; Comoglio F; Berg T; Beck J; Bohnenberger H; Alexe G; Corso J; Ströbel P; Wachter A; Beissbarth T; Schnütgen F; Cremer A; Haetscher N; Göllner S; Rouhi A; Palmqvist L; Rieger MA; Schroeder T; Bönig H; Müller-Tidow C; Kuchenbauer F; Schütz E; Green AR; Urlaub H; Stegmaier K; Humphries RK; Serve H; Oellerich T
    Cancer Cell; 2017 Apr; 31(4):549-562.e11. PubMed ID: 28399410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice.
    Staffas A; Arabanian LS; Wei SY; Jansson A; Ståhlman S; Johansson P; Fogelstrand L; Cammenga J; Kuchenbauer F; Palmqvist L
    Oncogene; 2017 Mar; 36(11):1516-1524. PubMed ID: 27617578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.
    Li Z; Huang H; Chen P; He M; Li Y; Arnovitz S; Jiang X; He C; Hyjek E; Zhang J; Zhang Z; Elkahloun A; Cao D; Shen C; Wunderlich M; Wang Y; Neilly MB; Jin J; Wei M; Lu J; Valk PJM; Delwel R; Lowenberg B; Le Beau MM; Vardiman J; Mulloy JC; Zeleznik-Le NJ; Liu PP; Zhang J; Chen J
    Nat Commun; 2012 Feb; 3():688. PubMed ID: 22353710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The miR-17∼92 cluster contributes to MLL leukemia through the repression of MEIS1 competitor PKNOX1.
    Mian YA; Zeleznik-Le NJ
    Leuk Res; 2016 Jul; 46():51-60. PubMed ID: 27123834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.
    Wang GG; Pasillas MP; Kamps MP
    Blood; 2005 Jul; 106(1):254-64. PubMed ID: 15755900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc.
    Garcia-Cuellar MP; Prinz A; Slany RK
    Haematologica; 2022 Nov; 107(11):2601-2616. PubMed ID: 35546301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation.
    Morgado E; Albouhair S; Lavau C
    Blood; 2007 May; 109(9):4020-2. PubMed ID: 17202314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development.
    Schneider E; Staffas A; Röhner L; Krowiorz K; Heuser M; Döhner K; Bullinger L; Döhner H; Fogelstrand L; Rouhi A; Kuchenbauer F; Palmqvist L
    Exp Hematol; 2016 Dec; 44(12):1166-1171. PubMed ID: 27619068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.
    Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH
    J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias.
    Lawrence HJ; Rozenfeld S; Cruz C; Matsukuma K; Kwong A; Kömüves L; Buchberg AM; Largman C
    Leukemia; 1999 Dec; 13(12):1993-9. PubMed ID: 10602420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEIS1 and HOXA7 genes in human acute myeloid leukemia.
    Afonja O; Smith JE; Cheng DM; Goldenberg AS; Amorosi E; Shimamoto T; Nakamura S; Ohyashiki K; Ohyashiki J; Toyama K; Takeshita K
    Leuk Res; 2000 Oct; 24(10):849-55. PubMed ID: 10996203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis.
    Hu YL; Fong S; Ferrell C; Largman C; Shen WF
    Mol Cell Biol; 2009 Sep; 29(18):5181-92. PubMed ID: 19620287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of the HOXA9/MEIS1 axis in acute leukemia.
    Collins CT; Hess JL
    Curr Opin Hematol; 2016 Jul; 23(4):354-61. PubMed ID: 27258906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia.
    Zhu G; Luo H; Feng Y; Guryanova OA; Xu J; Chen S; Lai Q; Sharma A; Xu B; Zhao Z; Feng R; Ni H; Claxton D; Guo Y; Mesa RA; Qiu Y; Yang FC; Li W; Nimer SD; Huang S; Xu M
    Nat Commun; 2021 Mar; 12(1):1956. PubMed ID: 33782403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meis2 as a critical player in MN1-induced leukemia.
    Lai CK; Norddahl GL; Maetzig T; Rosten P; Lohr T; Sanchez Milde L; von Krosigk N; Docking TR; Heuser M; Karsan A; Humphries RK
    Blood Cancer J; 2017 Sep; 7(9):e613. PubMed ID: 28960191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.
    Hassan JJ; Lieske A; Dörpmund N; Klatt D; Hoffmann D; Kleppa MJ; Kustikova OS; Stahlhut M; Schwarzer A; Schambach A; Maetzig T
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502319
    [No Abstract]   [Full Text] [Related]  

  • 20. Dangerous liaisons: cooperation between Pbx3, Meis1 and Hoxa9 in leukemia.
    Thorne RM; Milne TA
    Haematologica; 2015 Jul; 100(7):850-3. PubMed ID: 26130510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.